Video Experimental Relacionado
Updated: Jul 12, 2026
09:06
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Modelos de aprendizaje profundo identifican cambios cerebrales durante la progresión de la enfermedad de Alzheimer
Jinhui Sun1, Jing-Dong J Han2, Weiyang Chen3
1School of Cyber Science and Engineering, Qufu Normal University, Qufu, China.
NPJ systems biology and applications
|February 19, 2026
Resumen
Este estudio presenta una novedosa red de IA para analizar escáneres cerebrales a lo largo del tiempo, mejorando el diagnóstico de la enfermedad de Alzheimer (EA). Los hallazgos revelan cambios dinámicos en las regiones del cerebro durante la progresión de la EA, lo que ayuda a la detección temprana.
Área de la Ciencia:
- Neuroimagen
- Inteligencia artificial
- Enfermedades neurodegenerativas
Sus antecedentes:
- El diagnóstico de la enfermedad de Alzheimer (EA) a menudo se basa en datos de un solo punto en el tiempo, descuidando su naturaleza progresiva.
- El análisis longitudinal de la resonancia magnética estructural (sMRI) es crucial para comprender la progresión de la EA.
- Se necesita la integración de características multitejido y dinámicas temporales para modelos de diagnóstico avanzados de EA.
Objetivo del estudio:
- Desarrollar y validar una novedosa red de aprendizaje profundo para el diagnóstico de la enfermedad de Alzheimer utilizando datos sMRI longitudinales.
- Investigar los cambios dinámicos en las regiones del cerebro asociadas con la enfermedad de Alzheimer y el envejecimiento normal.
- Mejorar la comprensión patológica y las capacidades de diagnóstico temprano para la enfermedad de Alzheimer.
Principales métodos:
- Se propuso una Red de Atención de Canal de Fusión Multibrancho (MBFCA-Net) para analizar datos sMRI multitiempo.
- Se aprovecharon las correlaciones temporales a través de escaneos longitudinales para la detección de la enfermedad de Alzheimer.
- Se realizó un análisis retrospectivo de interpretabilidad para cuantificar las contribuciones regionales del cerebro en las diferentes etapas de la enfermedad.
Principales resultados:
- La MBFCA-Net utilizó eficazmente datos de escaneo longitudinales para el diagnóstico de la enfermedad de Alzheimer.
- Identificó cambios dinámicos en la importancia de regiones cerebrales como la amígdala, el giro parahipocampal y el lóbulo temporal durante la progresión de la EA.
- Se observó una tendencia de desarrollo en los clústeres de vóxeles relacionados con la EA, que se desplazaron del hipocampo al lóbulo temporal.
Conclusiones:
- El estudio destaca la importancia de los datos longitudinales y los modelos avanzados de IA para el diagnóstico de la enfermedad de Alzheimer.
- Reveló alteraciones dinámicas y específicas de la etapa en regiones cerebrales críticas para la comprensión de la EA.
- Proporciona información novedosa sobre los patrones longitudinales de la EA, apoyando el diagnóstico temprano y la comprensión de la enfermedad.
Palabras clave:
enfermedad de Alzheimeraprendizaje profundoneuroimagenresonancia magnética estructuralanálisis longitudinaldiagnóstico de la enfermedadcambios cerebralesdetección tempranaredes neuronalesatención de canalMás Videos Relacionados
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Videos de Conceptos Relacionados
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...